Health Catalyst, Inc. (HCAT)
Stock Price Chart
Key Info
| Market Cap | 1.20B |
| Revenue (ttm) | 164.84M |
| Net Income (ttm) | -63.87M |
| Shares Out | 38.01M |
| EPS (ttm) | -28.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Jul 7, 2020 |
| Last Price | $31.55 |
| Previous Close | $31.51 |
| Change ($) | 0.04 |
| Change (%) | 0.13% |
| Day's Open | 30.58 |
| Day's Range | 30.05 - 31.52 |
| Day's Volume | 203 |
| 52-Week Range | 17.48 - 49.85 |
More Stats
| Market Cap | 1.20B |
| Enterprise Value | 1.05B |
| Earnings Date (est) | Aug 20, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 38.01M |
| Float | 26.35M |
| EPS (basic) | -18.93 |
| EPS (diluted) | -28.31 |
| FCF / Share | -1.24 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 6.30M |
| Short Ratio | 11.33 |
| Short % of Float | 23.17% |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 7.27 |
| PB Ratio | 5.89 |
| Revenue | 164.84M |
| Operating Income | -61.88M |
| Net Income | -63.87M |
| Free Cash Flow | -45.89M |
| Net Cash | 152.40M |
| Net Cash / Share | 4.01 |
| Gross Margin | 48.35% |
| Operating Margin | -37.54% |
| Profit Margin | -109.60% |
| FCF Margin | -27.84% |
| ROA | -16.93% |
| ROE | -53.22% |
| ROIC | -31.40% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|---|---|---|
| Revenue | 155 | 113 | 73.08 |
| Revenue Growth | 37.63% | 54.04% | - |
| Gross Profit | 79.60 | 52.72 | 29.44 |
| Operating Income | -54.87 | -60.10 | -45.54 |
| Net Income | -60.10 | -61.98 | -47.04 |
| Shares Outstanding | 18.74 | 4.80 | 4.85 |
| Earnings Per Share | -12.86 | -23.76 | -12.13 |
| Operating Cash Flow | -32.18 | -40.30 | -36.83 |
| Capital Expenditures | -2.34 | -2.25 | -2.42 |
| Free Cash Flow | -34.52 | -42.54 | -39.25 |
| Cash & Equivalents | 228 | 33.19 | 51.46 |
| Total Debt | 52.66 | 26.91 | 12.62 |
| Net Cash / Debt | 176 | 6.29 | 38.84 |
| Assets | 302 | 111 | 110 |
| Liabilities | 102 | 75.90 | 48.17 |
| Book Value | 201 | -375 | 62.09 |
Company Profile
Company Details
| Full Name | Health Catalyst, Inc. |
| Country | United States |
| Employees | 900 |
| CEO | Daniel D. Burton |
Stock Information
| Ticker Symbol | HCAT |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Unique Identifier | NASDAQ: HCAT |
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations primarily in the United States. The company operates through two segments, Technology and Professional services. Its products include cloud-based data platform, analytics software, and professional services. The company offers Data Operating System (DOS), a data platform that allows customers to integrate and organize their disparate data sources to enable analytics, including healthcare-specific terminology, data governance, and meta-data management. It also develops foundational software applications comprising Population Builder application that enables clinicians and administrators to author, manage, view, and publish pre-built and custom population ruleset definitions; Touchstone application for benchmarking solutions; and Leading Wisely application for dashboards and reporting solutions. In addition, the company provides domain-specific software applications, such as CORUS application for activity-based costing; patient safety monitor analytics; care management services; population health foundations solutions; and quality and regulatory measures solutions. Further, it offers analytics accelerators, which facilitate analytic insights across clinical, financial, and operational use-cases. Additionally, the company provides data and analytics services, including data engineering, analytic engineer, implementation, data science, analytics strategy, and data governance services; and clinical, financial, and operational services comprising quality and process improvement strategy, patient safety, cost accounting, population health and value-based care, abstraction data submission, and health catalyst university educational services. The company was founded in 2008 and is headquartered in Salt Lake City, Utah.